Intravenous Immunoglobulins as a new opportunity to treat discoid lupus erythematosus

Walling, 2009, Cutaneous lupus erythematosus: issues in diagnosis and treatment, Am J Clin Dermatol, 10, 365, 10.2165/11310780-000000000-00000 Okon, 2013, Cutaneous lupus erythematosus: diagnosis and treatment, Best Pract Res Clin Rheumatol, 27, 391, 10.1016/j.berh.2013.07.008 Kuhn, 2014, The classification and diagnosis of cutaneous lupus erythematosus, J Autoimmun, 48-49, 14, 10.1016/j.jaut.2014.01.021 Elman, 2017, Development of classification criteria for discoid lupus erythematosus: results of a Delphi exercise, J Am Acad Dermatol, 77, 261, 10.1016/j.jaad.2017.02.030 Zhang, 2017, Pathogenesis of cutaneous lupus erythema associated with and without systemic lupus erythema, Autoimmun Rev, 16, 735, 10.1016/j.autrev.2017.05.009 Jessop, 2017, Drugs for discoid lupus erythematosus, Cochrane Database Syst Rev, 5 Sigges, 2013, Therapeutic strategies evaluated by the European Society of Cutaneous Lupus Erythematosus (EUSCLE) Core Set Questionnaire in more than 1000 patients with cutaneous lupus erythematosus, Autoimmun Rev, 12, 694, 10.1016/j.autrev.2012.10.005 Garza-Mayers, 2016, Review of treatment for discoid lupus erythematosus, Dermatol Ther, 29, 274, 10.1111/dth.12358 Kivity, 2010, Evidence for the use of intravenous immunoglobulins–a review of the literature, Clin Rev Allergy Immunol, 38, 201, 10.1007/s12016-009-8155-9 Tenti, 2016, Intravenous immunoglobulins and antiphospholipid syndrome: how, when and why? A review of the literature, Autoimmun Rev, 15, 226, 10.1016/j.autrev.2015.11.009 Guidelli, 2015, Granulomatosis with polyangiitis and intravenous immunoglobulins: a case series and review of the literature, Autoimmun Rev, 14, 659, 10.1016/j.autrev.2015.03.005 Piette, 1995, High-dose immunoglobulins in the treatment of refractory cutaneous lupus erythematosus: open trial in 5 patients, Arthritis Rheum, 38, S304 De Pità, 1997, Intravenous immunoglobulin therapy is not able to efficiently control cutaneous manifestations in patients with lupus erythematosus, Lupus, 6, 415, 10.1177/096120339700600414 Wollina, 1998, Intravenous immunoglobulin therapy in dermatology: overview and center experience, An Bras Dermatol, 73, 255 Généreau, 1999, High-dose intravenous immunoglobulin in cutaneous lupus erythematosus, Arch Dermatol, 135, 1124, 10.1001/archderm.135.9.1124 Levy, 1999, A study of 20 SLE patients with intravenous immunoglobulin–clinical and serologic response, Lupus, 8, 705, 10.1191/096120399678841007 Goodfield, 2004, Intravenous immunoglobulin (IVIg) for therapy-resistant cutaneous lupus erythematosus (LE), J Dermatolog Treat, 15, 46, 10.1080/09546630310018789 Kreuter, 2005, Intravenous immunoglobulin for recalcitrant subacute cutaneous lupus erythematosus, Acta Derm Venereol, 85, 545, 10.1080/00015550510037071 Lampropoulos, 2007, Intravenous immunoglobulin in the treatment of resistant subacute cutaneous lupus erythematosus: a possible alternative, Clin Rheumatol, 26, 981, 10.1007/s10067-006-0222-5 Ky, 2015, Efficacy of intravenous immunoglobulin monotherapy in patients with cutaneous lupus erythematosus: results of proof-of-concept study, Dermatol Rep, 7, 5804, 10.4081/dr.2015.5804 Hsu, 2017, Cumulative immunosuppressant exposure is associated with diversified cancer risk among 14 832 patients with systemic lupus erythematosus: a nested case-control study, Rheumatology (Oxford), 56, 620 Arvanitidou, 2018, Multiple primary squamous cell carcinomas of the lower lip and tongue arising in discoid lupus erythematosus: a case report, Oral Surg Oral Med Oral Pathol Oral Radiol, 125, 10.1016/j.oooo.2017.08.012 Gelfand, 2012, Intravenous immune globulin in autoimmune and inflammatory diseases, N Engl J Med, 367, 2015, 10.1056/NEJMra1009433 Basyreva, 2016, The effect of Intravenous Immunoglobulin (IVIG) on \textit{ex vivo} activation of human leukocytes, Hum Antibodies, 24, 39, 10.3233/HAB-160293 Sherer, 2008, Low dose intravenous immunoglobulin in systemic lupus erythematosus: analysis of 62 cases, Isr Med Assoc J, 10, 55 Tenti, 2013, Long-term treatment of antiphospholipid syndrome with intravenous immunoglobulin in addition to conventional therapy, Clin Exp Rheumatol, 31, 877 Shoenfeld, 2005, IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patients, Autoimmunity, 38, 123, 10.1080/08916930500059633